emergent logo.jpg
Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months of 2018
02 août 2018 16h30 HE | Emergent BioSolutions
Q2 2018 total revenues of $220 million, net income of $50 millionReaffirms full year 2018 financial forecast and operational goals GAITHERSBURG, Md., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Emergent...
emergent logo.jpg
Emergent BioSolutions Reports First Quarter 2018 Financial Results
03 mai 2018 16h30 HE | Emergent BioSolutions
Reaffirms full year 2018 financial forecast and operational goalsProvides Q2 2018 revenue forecast of $205M-$230M GAITHERSBURG, Md., May 03, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions...
emerge.png
Emergent BioSolutions to Release Third Quarter and Nine Months 2017 Financial Results and Conduct a Conference Call on November 2, 2017
19 oct. 2017 07h00 HE | Emergent Biosolutions, Inc.
GAITHERSBURG, Md., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) will release its financial results for the third quarter and nine months of 2017 immediately after market close...
emerge.png
Emergent BioSolutions to Release First Quarter 2017 Financial Results and Conduct a Conference Call on May 4, 2017
20 avr. 2017 07h00 HE | Emergent BioSolutions Inc.
GAITHERSBURG, Md., April 20, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, May 4, 2017 at 5:00 pm (Eastern Time) to discuss the financial...
emerge.png
Emergent BioSolutions to Release Fourth Quarter and Full Year 2015 Financial Results and Conduct a Conference Call on February 25, 2016
11 févr. 2016 07h01 HE | Emergent Biosolutions, Inc.
GAITHERSBURG, Md., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 25, 2016 at 5:00 pm (Eastern Time) to discuss the...
emerge.png
Emergent BioSolutions Reports Third Quarter and Nine Months 2015 Financial Results
05 nov. 2015 16h15 HE | Emergent Biosolutions, Inc.
GAITHERSBURG, Md., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and nine months ended September 30, 2015. FINANCIAL...